Kapiva launches ₹50 Cr innovation fund for ayurveda research
By Abha Lohia · Editor ·
Kapiva: revenue and funding and every story →
BengaluruFounded 2016
- Kapiva launched a ₹50 Cr innovation fund for ayurvedic research and new product development
- The fund will back research institutions, PhD scholars, hospitals, labs, and startups
- It will support clinically tested solutions and AI in Ayurveda, with capital from its last fundraise
What happened
- Kapiva launched an innovation fund worth ₹50 Cr for ayurveda research.
- The fund will back projects from research institutions, PhD scholars, hospitals, labs, and startups.
- It will focus on ayurvedic research, new product development, and AI in Ayurveda.
- The fund will support clinically tested solutions for real health problems.
- Early-stage research projects can get up to ₹50 Lakh each.
- Late-stage research projects can get ₹4-6 Cr each.
- Applications open from 26 February 2026.
- Kapiva will offer access to in-house experts and expand its R&D facility in Bengaluru.
Why it matters
- Many researchers and startups lack resources to build better ayurvedic products.
- Demand for natural and herbal wellness products is rising in India.
- The Indian ayurvedic products market is expected to reach ₹3.21 Lakh Cr by 2032, growing at 17% CAGR.
The business
- Kapiva sells ayurvedic nutrition and wellness products: supplements, gummies, capsules, and skincare.
- It offers over 100 products.
- It provides consultations with ayurvedic doctors.
- Top categories include diabetes care, gym and sports nutrition, energy, and liver and heart health.
- Its highest-selling segment is the diabetes supplement category.
- Sales channels include its own D2C website, online marketplaces, and offline retail stores.
The founders
AS
Ameeve Sharma
cofounder- Co-founded Kapiva in 2016.
- Stated that the fund capital comes from the last fundraise.
SB
Shrey Badhani
cofounder- Co-founded Kapiva in 2016.
In numbers
₹50 CrFund size · 2026
~$120 MnTotal funding to date · 2026
$60 Mn (₹532 Cr)Last round amount · 2025
over 100Number of products · 2026
₹3.21 Lakh CrIndian ayurvedic products market size forecast · 2032
17%Market CAGR · 2032
What happens next
- Kapiva plans to go public in the next two to three years.
Earlier rounds
- September 2025 · Series D · $60 Mn (₹532 Cr)
Up against
OZivaHimalayan OrganicsThe Ayurveda CoDaburHimalayaPatanjali
Words to know
- Innovation fund
- A pool of money set aside by a company to invest in new ideas, research, or startups.
- Ayurveda
- An ancient Indian system of medicine that uses natural herbs and treatments.
- D2C
- Direct-to-consumer, selling products directly to customers without intermediaries.
- CAGR
- Compound annual growth rate, the average yearly growth rate over a period.
The numbers around it
Healthcare & Life Sciences in February 2026: 18 rounds with a disclosed amount, $66.5 million in all; the biggest was Pandorum Technologies ($18M). Every sector this year →
Terms in this story
- Startup: A startup is a young company built to find a new way of doing something and to grow fast, usually by serving many customers at little extra cost. India also has a legal definition for scheme benefits: under ten years old, turnover under ₹200 crore, and working on innovation or a scalable model.
Read next
LaunchKapiva gives away Dia Free Juice on World Diabetes DayKapiva is a Bengaluru-based Ayurveda wellness brand selling herbal juices and supplements, with a flagship juice aimed at people managing blood sugarFundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centres
Everything on Kapiva → · All startup news on 26 February 2026 →
Is this Kapiva? Get your “Featured on StopDown” badge →